Sabrina Sacconi
Nice, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 151 publications
Comprehensive Care Goals in Myasthenia Gravis: Expert Consensus Recommendations Using the RAND/UCLA Appropriateness Method.
Journal: Neurology. Clinical practice
Published: July 09, 2026
Real-world effectiveness and safety of zilucoplan in patients with anti-AChR myasthenia gravis: A retrospective cohort study in France.
Journal: Journal of neuromuscular diseases
Published: March 29, 2026
Not only cross-sectional area: Echogenicity matters in nerve ultrasound studies of patients with motor multifocal neuropathy.
Journal: Journal of neuromuscular diseases
Published: March 04, 2026
A randomized, double-blind, placebo-controlled study of losmapimod in patients with facioscapulohumeral muscular dystrophy: Results of the REACH study.
Journal: Journal of neuromuscular diseases
Published: February 06, 2026
Bridging past and future: the evolution of genetic diagnosis in FSHD and the role of emerging technologies in a globalized framework.
Journal: Neuromuscular disorders : NMD
Published: February 06, 2026
Active-NDM: Development of a patient-reported outcome questionnaire to measure the impact of non-dystrophic myotonia on activity of daily living.
Journal: Journal of neuromuscular diseases
Published: February 02, 2026
Long-term use of rozanolixizumab in generalised myasthenia gravis: final pooled analysis of the phase III MycarinG study and two open-label extensions.
Journal: Therapeutic advances in neurological disorders
Published: December 24, 2025
French National Protocol for Diagnosis and Care of Calpainopathy (LGMD R1/LGMD D4): consensus guidelines for clinical practice.
Journal: Orphanet journal of rare diseases
Published: December 16, 2025
Real-Life Effectiveness After Switching to Avalglucosidase Alfa in Late-Onset Pompe Disease Patients Worsening on Alglucosidase Alfa Therapy: A French Cohort Study.
Journal: European journal of neurology
Published: November 23, 2025
Late-onset facioscapulohumeral muscular dystrophy defines a distinct clinical subgroup.
Journal: Neuromuscular disorders : NMD
Published: November 14, 2025
Last Updated: 09/26/2026